Buy Rexahn Pharmaceuticals Inc. Stock | REXN Stock Price & Latest News | Public
REXN

Rexahn Pharmaceuticals Inc.

    Small Market Cap

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About REXN

    Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in F...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.44
    -0.88
    -1.32
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.42

    Actual EPS
    Q4 2020

    Stats

    Market Cap$10,85M
    Volume402
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$17.04
    1 Year Low$3.68
    Open$6.05
    High$6.29
    Low$6.05

    Buy any stock with any amount of money.

    Download the App
    Download the app